GLP-1RAs and opioid use disorder: a new frontier in addiction treatment
Glucagon-like peptide receptor agonists (GLP-1RAs) like Novo Nordisk’s semaglutide (Ozempic, Wegovy) and Eli Lilly’s ...
Many adults stop GLP-1 therapy within a year with low restart rates, analysis finds
A study conducted using electronic health record data from a collective of U.S. health care systems found that most adults ...
Does Ozempic Affect The Skin? An Expert Weighs In
Dr. Corey L. Hartman tells ESSENCE how this prescription can have long-term effects not just the body—but also on our skin.
Rolling Out20h
This antibody prevents muscle loss in weight loss drugs
Research shows bimagrumab may prevent muscle and bone loss associated with weight loss medications like Wegovy, offering hope ...
Medical News Today21h
What's the latest on cholesterol, heart health, GLP-1 drugs, and more?
This article showcases a curated list of standout studies over the last week on topics such as cholesterol, GLP-1 drugs for ...
Man, 52, ‘cured’ of his 15-year cocaine habit after taking weight loss jab in first case of its kind
A 52-year-old man has knocked his decade-long cocaine addiction on the head after receiving weight-loss injections. The jab ...
Zepbound for Weight Loss
The new weight loss drug offers promising results for those who are overweight or obese. Learn about how Zepbound works, its ...
Daily22h
Consensus on Peri-Op Management of GLP-1, GIP, & SGLT-2 Inhibitors released
UK: A recent consensus statement from leading UK medical organizations—including the Association of Anaesthetists, the ...